Mark Low is Managing Director of both the Global Cardiovascular Innovation Center (GCIC) and the NIH Center for Accelerated Innovations (NCAI) at Cleveland Clinic. He comes to these roles with a career of building successful programs to introduce new technologies to address new market opportunities in healthcare. He has managed all facets of product and market development spanning diagnostic and interventional cardiology, interventional radiology and neuroradiology, stroke treatment, image-guided surgery, drug delivery and oncology. He has served on the senior management team of TomTec Imaging Systems, Image Guided Technologies, EKOS Corporation, and Sonus Pharmaceuticals and in senior consultant roles to a half dozen other start-up companies. Prior to concentrating his focus on start-up ventures and early stage market development, Mark held lead positions in marketing and business development for Hewlett-Packard's Medical Products Group (now Philips Healthcare). Specializing in cardiovascular ultrasound, he managed high performance cardiac diagnostic systems, introducing 3D and stress echocardiography, and catheter-based intravascular ultrasound, among other applications. In conjunction with these programs Mark managed strategic relationships with various corporate partners, investors, universities, inventors, clinical investigators and manufacturers. Mark received a B.A. degree in Natural Science from Johns Hopkins University, an M.S. degree in Physiology from the Medical College of Wisconsin, and an M.S. degree in Technical Communication from Rensselaer Polytechnic Institute.